vs

Side-by-side financial comparison of ALLIANCE RESOURCE PARTNERS LP (ARLP) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $516.0M, roughly 1.9× ALLIANCE RESOURCE PARTNERS LP). ALLIANCE RESOURCE PARTNERS LP runs the higher net margin — 2.1% vs -15.2%, a 17.3% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -3.6%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $13.3M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -6.7%).

Alliance Resource Partners LP is a leading North American natural resource enterprise primarily engaged in the production and marketing of coal for utility and industrial customers. It also operates complementary business segments including mineral royalty management, oil and gas extraction, and logistics support services.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

ARLP vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.9× larger
XRAY
$961.0M
$516.0M
ARLP
Growing faster (revenue YoY)
XRAY
XRAY
+9.8% gap
XRAY
6.2%
-3.6%
ARLP
Higher net margin
ARLP
ARLP
17.3% more per $
ARLP
2.1%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$46.7M more FCF
XRAY
$60.0M
$13.3M
ARLP
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-6.7%
ARLP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ARLP
ARLP
XRAY
XRAY
Revenue
$516.0M
$961.0M
Net Profit
$10.7M
$-146.0M
Gross Margin
46.1%
Operating Margin
4.2%
-14.5%
Net Margin
2.1%
-15.2%
Revenue YoY
-3.6%
6.2%
Net Profit YoY
66.0%
EPS (diluted)
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARLP
ARLP
XRAY
XRAY
Q1 26
$516.0M
Q4 25
$535.5M
$961.0M
Q3 25
$571.4M
$904.0M
Q2 25
$547.5M
$936.0M
Q1 25
$540.5M
$879.0M
Q4 24
$590.1M
$905.0M
Q3 24
$613.6M
$951.0M
Q2 24
$593.4M
$984.0M
Net Profit
ARLP
ARLP
XRAY
XRAY
Q1 26
$10.7M
Q4 25
$82.7M
$-146.0M
Q3 25
$95.1M
$-427.0M
Q2 25
$59.4M
$-45.0M
Q1 25
$74.0M
$20.0M
Q4 24
$16.3M
$-430.0M
Q3 24
$86.3M
$-494.0M
Q2 24
$100.2M
$-4.0M
Gross Margin
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Operating Margin
ARLP
ARLP
XRAY
XRAY
Q1 26
4.2%
Q4 25
18.2%
-14.5%
Q3 25
18.4%
-24.1%
Q2 25
16.2%
-13.7%
Q1 25
17.4%
7.2%
Q4 24
2.6%
-56.2%
Q3 24
16.5%
-48.6%
Q2 24
19.8%
5.1%
Net Margin
ARLP
ARLP
XRAY
XRAY
Q1 26
2.1%
Q4 25
15.4%
-15.2%
Q3 25
16.6%
-47.2%
Q2 25
10.9%
-4.8%
Q1 25
13.7%
2.3%
Q4 24
2.8%
-47.5%
Q3 24
14.1%
-51.9%
Q2 24
16.9%
-0.4%
EPS (diluted)
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
$-0.74
Q3 25
$-2.14
Q2 25
$-0.22
Q1 25
$0.10
Q4 24
$-2.09
Q3 24
$-2.46
Q2 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARLP
ARLP
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$28.9M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$1.3B
Total Assets
$2.9B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARLP
ARLP
XRAY
XRAY
Q1 26
$28.9M
Q4 25
$71.2M
$326.0M
Q3 25
$94.5M
$363.0M
Q2 25
$55.0M
$359.0M
Q1 25
$81.3M
$398.0M
Q4 24
$137.0M
$272.0M
Q3 24
$195.4M
$296.0M
Q2 24
$203.7M
$279.0M
Total Debt
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Stockholders' Equity
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
$1.3B
Q3 25
$1.5B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.9B
Q3 24
$2.5B
Q2 24
$3.1B
Total Assets
ARLP
ARLP
XRAY
XRAY
Q1 26
$2.9B
Q4 25
$2.9B
$5.4B
Q3 25
$2.9B
$5.7B
Q2 25
$2.9B
$6.1B
Q1 25
$2.9B
$6.0B
Q4 24
$2.9B
$5.8B
Q3 24
$3.0B
$6.6B
Q2 24
$3.1B
$6.9B
Debt / Equity
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARLP
ARLP
XRAY
XRAY
Operating Cash FlowLast quarter
$101.0M
Free Cash FlowOCF − Capex
$13.3M
$60.0M
FCF MarginFCF / Revenue
2.6%
6.2%
Capex IntensityCapex / Revenue
18.5%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$342.2M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
$143.9M
$101.0M
Q3 25
$209.9M
$79.0M
Q2 25
$151.7M
$48.0M
Q1 25
$145.7M
$7.0M
Q4 24
$168.4M
$87.0M
Q3 24
$209.3M
$141.0M
Q2 24
$215.8M
$208.0M
Free Cash Flow
ARLP
ARLP
XRAY
XRAY
Q1 26
$13.3M
Q4 25
$99.1M
$60.0M
Q3 25
$145.2M
$40.0M
Q2 25
$84.7M
$16.0M
Q1 25
$58.9M
$-12.0M
Q4 24
$75.3M
$36.0M
Q3 24
$99.0M
$98.0M
Q2 24
$114.3M
$156.0M
FCF Margin
ARLP
ARLP
XRAY
XRAY
Q1 26
2.6%
Q4 25
18.5%
6.2%
Q3 25
25.4%
4.4%
Q2 25
15.5%
1.7%
Q1 25
10.9%
-1.4%
Q4 24
12.8%
4.0%
Q3 24
16.1%
10.3%
Q2 24
19.3%
15.9%
Capex Intensity
ARLP
ARLP
XRAY
XRAY
Q1 26
18.5%
Q4 25
8.4%
4.3%
Q3 25
11.3%
4.3%
Q2 25
12.2%
3.4%
Q1 25
16.1%
2.2%
Q4 24
15.8%
5.6%
Q3 24
18.0%
4.5%
Q2 24
17.1%
5.3%
Cash Conversion
ARLP
ARLP
XRAY
XRAY
Q1 26
Q4 25
1.74×
Q3 25
2.21×
Q2 25
2.55×
Q1 25
1.97×
0.35×
Q4 24
10.31×
Q3 24
2.43×
Q2 24
2.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARLP
ARLP

Coal sales$443.3M86%
Oil & gas royalties$41.3M8%
Other revenues$22.8M4%
Transportation revenues$8.6M2%
Tons Produced$8.0M2%
Mineral Interest Volumes (BOE)$1.0M0%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons